IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v190y2017icp190-198.html
   My bibliography  Save this article

Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine

Author

Listed:
  • Sobo, Elisa J.

Abstract

Cannabis is an increasingly sought-after remedy for US children with intractable (biomedically uncontrollable) epilepsy. However, like other complementary-alternative medicine (CAM) modalities, and particularly as a federally illegal, stigmatized substance, it is unsanctioned by mainstream medicine. Parents are largely on their own when it comes to learning about, procuring, dispensing, and monitoring treatments. Exploring how they manage is crucial to better assist them. Moreover, it can illuminate how ‘research’ done on the ground by laypeople variously disrupts and reinforces lay–expert and science–non-science divides. To those ends, in 2016, 25 Southern California parents who used, had used, or sought to use cannabis pediatrically for epilepsy/seizures were interviewed regarding their evidentiary standards, research methods, and aims when trying the drug. Parents generally described their work as experimentation; they saw their efforts as adhering to authorized scientific practices and standards, and as contributing to the authorized medical cannabis knowledge base. Findings subverted assumptions, based on an outdated stereotype of CAM, that cannabis-using parents do not believe in biomedicine. Indeed, parents' desire for their children's biomedical demarginalization, combined with biomedical dependency and a high caregiver burden, fueled a collaborative stance. Implications for understanding the boundaries of science are explored, as are norms for parent agency as ill children's care managers, radicalization among people affected by contested illnesses, and the future of ‘medical marijuana.’

Suggested Citation

  • Sobo, Elisa J., 2017. "Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine," Social Science & Medicine, Elsevier, vol. 190(C), pages 190-198.
    • Handle: RePEc:eee:socmed:v:190:y:2017:i:c:p:190-198
    DOI: 10.1016/j.socscimed.2017.08.003
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953617304756
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2017.08.003?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Bell, Susan E. & Figert, Anne E., 2012. "Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward," Social Science & Medicine, Elsevier, vol. 75(5), pages 775-783.
    2. De Vries, Raymond & Lemmens, Trudo, 2006. "The social and cultural shaping of medical evidence: Case studies from pharmaceutical research and obstetric science," Social Science & Medicine, Elsevier, vol. 62(11), pages 2694-2706, June.
    3. Lambert, Helen, 2006. "Accounting for EBM: Notions of evidence in medicine," Social Science & Medicine, Elsevier, vol. 62(11), pages 2633-2645, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zarhin, Dana & Negev, Maya & Vulfsons, Simon & Sznitman, Sharon R., 2018. "Rhetorical and regulatory boundary-work: The case of medical cannabis policy-making in Israel," Social Science & Medicine, Elsevier, vol. 217(C), pages 1-9.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Perrotta, Manuela & Geampana, Alina, 2020. "The trouble with IVF and randomised control trials: Professional legitimation narratives on time-lapse imaging and evidence-informed care," Social Science & Medicine, Elsevier, vol. 258(C).
    2. Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
    3. Timmermans, Stefan & Almeling, Rene, 2009. "Objectification, standardization, and commodification in health care: A conceptual readjustment," Social Science & Medicine, Elsevier, vol. 69(1), pages 21-27, July.
    4. Blume, Stuart & Tump, Janneke, 2010. "Evidence and policymaking: The introduction of MMR vaccine in the Netherlands," Social Science & Medicine, Elsevier, vol. 71(6), pages 1049-1055, September.
    5. Dew, Kevin & Norris, Pauline & Gabe, Jonathan & Chamberlain, Kerry & Hodgetts, Darrin, 2015. "Moral discourses and pharmaceuticalised governance in households," Social Science & Medicine, Elsevier, vol. 131(C), pages 272-279.
    6. Scott, Clare & Walker, Jan & White, Peter & Lewith, George, 2011. "Forging convictions: The effects of active participation in a clinical trial," Social Science & Medicine, Elsevier, vol. 72(12), pages 2041-2048, June.
    7. Başaran, Oyman, 2020. "“The self-making of the scientific circumciser (fenni sünnetçi):” the medicalization of male circumcision in Turkey," Social Science & Medicine, Elsevier, vol. 265(C).
    8. Rubbio, Iacopo & Bruccoleri, Manfredi, 2023. "Unfolding the relationship between digital health and patient safety: The roles of absorptive capacity and healthcare resilience," Technological Forecasting and Social Change, Elsevier, vol. 195(C).
    9. Pavlova, Milena & Hendrix, Marijke & Nouwens, Elvira & Nijhuis, Jan & van Merode, Godefridus, 2009. "The choice of obstetric care by low-risk pregnant women in the Netherlands: Implications for policy and management," Health Policy, Elsevier, vol. 93(1), pages 27-34, November.
    10. Mamo, Laura & Epstein, Steven, 2014. "The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention," Social Science & Medicine, Elsevier, vol. 101(C), pages 155-165.
    11. Shelly Jun & Kelsea Drall & Brittany Matenchuk & Cara McLean & Charlene Nielsen & Chinwe V. Obiakor & Aaron Van der Leek & Anita Kozyrskyj, 2018. "Sanitization of Early Life and Microbial Dysbiosis," Challenges, MDPI, vol. 9(2), pages 1-9, December.
    12. Kris Hoang & Steven E. Salterio & Jim Sylph, 2018. "Barriers to Transferring Auditing Research to Standard Setters," Accounting Perspectives, John Wiley & Sons, vol. 17(3), pages 427-452, September.
    13. Moes, Floortje & Houwaart, Eddy & Delnoij, Diana & Horstman, Klasien, 2020. "Questions regarding ‘epistemic injustice’ in knowledge-intensive policymaking: Two examples from Dutch health insurance policy," Social Science & Medicine, Elsevier, vol. 245(C).
    14. Terrence D. Hill & Jason A. Ford & Harvey L. Nicholson, 2022. "Education and polypharmacy: A national study of racial and ethnic variations," Social Science Quarterly, Southwestern Social Science Association, vol. 103(7), pages 1687-1705, December.
    15. Reich, Adam, 2012. "Disciplined doctors: The electronic medical record and physicians' changing relationship to medical knowledge," Social Science & Medicine, Elsevier, vol. 74(7), pages 1021-1028.
    16. Sobo, Elisa J. & Bowman, Candice & Gifford, Allen L., 2008. "Behind the scenes in health care improvement: The complex structures and emergent strategies of Implementation Science," Social Science & Medicine, Elsevier, vol. 67(10), pages 1530-1540, November.
    17. Taipale, Jaakko & Hautamäki, Lotta, 2021. "Clinical practice guidelines in courts’ representation of medical evidence and testimony," Social Science & Medicine, Elsevier, vol. 275(C).
    18. Silje Gustafsson & Irene Vikman & Stefan Sävenstedt & Jesper Martinsson, 2015. "Perceptions of needs related to the practice of self‐care for minor illness," Journal of Clinical Nursing, John Wiley & Sons, vol. 24(21-22), pages 3255-3265, November.
    19. Pollock, Anne & Jones, David S., 2015. "Coronary artery disease and the contours of pharmaceuticalization," Social Science & Medicine, Elsevier, vol. 131(C), pages 221-227.
    20. Gutin, Iliya, 2022. "Not ‘putting a name to it’: Managing uncertainty in the diagnosis of childhood obesity," Social Science & Medicine, Elsevier, vol. 294(C).

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:190:y:2017:i:c:p:190-198. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.